Skip to content

Basket

You currently have no items in your basket.

Total (excl. vat) £0.00
View basket & checkout
Proteins and Peptides

SARS-CoV-2 Spike RBD Protein, His Tag (LF.7) (MALS verified)

Product Sizes
100 ug
£413.00
SPD-S52HG-100UG
1 mg
£2756.00
SPD-S52HG-1MG
About this Product
SKU:
SPD-S52HG
Buffer:
PBS
Extra Details:
The SARS-CoV-2 lineage LF.7 is a subvariant within the JN.1 family, identified through genomic surveillance in 2024-2025. It carries multiple Spike protein mutations, some within the receptor-binding domain, potentially affecting antibody recognition and viral fitness. LF.7 and its sublineages (e.g., LF.7.2.1) have been detected across several regions, showing moderate growth advantage over earlier strains. Preliminary studies suggest certain mutations may enhance immune evasion, though impacts on ACE2 binding vary. Continuous monitoring is recommended to assess its epidemiological significance, vaccine effectiveness, and role in ongoing SARS-CoV-2 evolution.
Immunogen:
Spike RBD
Molecular Weight:
26.7 kDa
Physical State:
Powder
Shipping Conditions:
Ambient
Storage Conditions:
-20[o]C
Supplier:
ACRO Biosystems
Type:
Proteins, Peptides, Small Molecules & Other Biomolecules: Recombinant Proteins
SARS-CoV-2 Spike RBD Protein, His Tag (LF.7) on SDS-PAGE under reducing (R) condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 90%.
Immobilized SARS-CoV-2 Spike RBD Protein, His Tag (LF.7) (Cat. No. SPD-S52Hg) at 5 ug/mL (100 uL/well) can bind Human ACE2, Fc Tag (Cat. No. AC2-H5257) with a linear range of 0.5-1 ng/mL (QC tested).